Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-027643

Director bought 1,069 shares at an average $2.61 ($2,791)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2022-04-16 Purchase +94 $2.71 $255 184,235 D
Krogulski Kenneth Director 2022-04-18 Purchase +94 $2.63 $247 184,329 D
Krogulski Kenneth Director 2022-04-19 Purchase +94 $2.69 $253 184,423 D
Krogulski Kenneth Director 2022-04-20 Purchase +94 $2.74 $258 184,517 D
Krogulski Kenneth Director 2022-04-21 Purchase +94 $2.75 $259 184,611 D
Krogulski Kenneth Director 2022-04-22 Purchase +94 $2.73 $257 184,705 D
Krogulski Kenneth Director 2022-04-25 Purchase +101 $2.62 $265 184,806 D
Krogulski Kenneth Director 2022-04-26 Purchase +101 $2.53 $256 184,907 D
Krogulski Kenneth Director 2022-04-27 Purchase +101 $2.41 $243 185,008 D
Krogulski Kenneth Director 2022-04-28 Purchase +101 $2.51 $254 185,109 D
Krogulski Kenneth Director 2022-04-29 Purchase +101 $2.44 $246 185,210 D
Open-market purchases · 1,069 sh · avg $2.61 · $2,791
Loading xslF345X03/doc4.xml…